A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension.

Trial Profile

A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Apr 2017

At a glance

  • Drugs Candesartan cilexetil/nifedipine (Primary) ; Candesartan cilexetil; Nifedipine
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms DISTINCT
  • Sponsors Bayer
  • Most Recent Events

    • 11 Aug 2016 Results of subgroup analysis published in the Journal of Human Hypertension
    • 01 Feb 2016 Subgroup analysis (n=1362) published in the Journal of Clinical Pharmacology.
    • 11 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top